| Bioactivity | HIV-1 inhibitor-35 (compound 74) is a potent HIV-1 inhibitor with EC50s of 80 nM and 70 nM for LTR and CMV in HEK293 cells, respectively. HIV-1 inhibitor-35 has inhibitory activity against liver cancer cell HepG2 with a CC50 of 40 nM. HIV-1 inhibitor-35 can be used as HIV-1 latency reversing agent[1]. |
| Target | HIV-1 |
| Name | HIV-1 inhibitor-35 |
| CAS | 2416971-32-7 |
| Formula | C13H12Cl3N5OS |
| Molar Mass | 392.69 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nguyen W, et al. Optimization of 5-substituted thiazolyl ureas and 6-substituted imidazopyridines as potential HIV-1 latency reversing agents. Eur J Med Chem. 2020;195:112254. |
HIV-1 inhibitor-35
CAS: 2416971-32-7 F: C13H12Cl3N5OS W: 392.69
HIV-1 inhibitor-35 (compound 74) is a potent HIV-1 inhibitor with EC50s of 80 nM and 70 nM for LTR and CMV in HEK293 cel
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.